Department of Respirology, Third Affiliated Hospital of Shenzhen University, Shenzhen, China.
Research Center of Allergy and Immunology, Shenzhen University School of Medicine, Shenzhen, China.
Clin Exp Immunol. 2019 May;196(2):276-286. doi: 10.1111/cei.13259. Epub 2019 Jan 30.
Dysfunction of the immune regulatory system plays an important role in the pathogenesis of rheumatoid arthritis (RA). Vasoactive intestinal peptide (VIP) has multiple bioactivities. This study aims to investigate the role of VIP in the maintenance of the immune regulatory capacity of monocytes (Mos). Human peripheral blood samples were collected from RA patients and healthy control (HC) subjects. Mos and CD14 CD71 CD73 CD25 regulatory Mos (RegMos) were isolated from the blood samples and characterized by flow cytometry. A rat RA model was developed to test the role of VIP in the maintenance of the immune regulatory function of Mos. The results showed that RegMos of HC subjects had immune suppressive functions. RegMos of RA patients expressed less interleukin (IL)-10 and showed an incompetent immune regulatory capacity. Serum levels of VIP were lower in RA patients, which were positively correlated with the expression of IL-10 in RegMos. In-vitro experiments showed that the IL-10 mRNA decayed spontaneously in RegMos, which could be prevented by the presence of VIP in the culture. VIP suppressed the effects of tristetraprolin (TTP) on inducing IL-10 mRNA decay in RegMos. Administration of VIP inhibited experimental RA in rats through restoring the IL-10 expression in RegMos. RegMos have immune suppressive functions. VIP is required in maintaining IL-10 expression in RegMos. The data suggest that VIP has translational potential in the treatment of immune disorders such as RA.
免疫调节系统功能障碍在类风湿关节炎(RA)的发病机制中起着重要作用。血管活性肠肽(VIP)具有多种生物活性。本研究旨在探讨 VIP 在维持单核细胞(Mos)免疫调节能力中的作用。从 RA 患者和健康对照(HC)受试者中采集外周血样本。通过流式细胞术从血液样本中分离 Mos 和 CD14 CD71 CD73 CD25 调节性 Mos(RegMos),并对其进行鉴定。建立大鼠 RA 模型以测试 VIP 在维持 Mos 免疫调节功能中的作用。结果表明,HC 受试者的 RegMos 具有免疫抑制功能。RA 患者的 RegMos 表达较少的白细胞介素(IL)-10,表现出功能失调的免疫调节能力。RA 患者的血清 VIP 水平较低,与 RegMos 中 IL-10 的表达呈正相关。体外实验表明,RegMos 中的 IL-10 mRNA 自发衰减,而 VIP 的存在可防止这种衰减。VIP 抑制了 tristetraprolin(TTP)在 RegMos 中诱导 IL-10 mRNA 衰减的作用。VIP 通过恢复 RegMos 中 IL-10 的表达来抑制大鼠实验性 RA。RegMos 具有免疫抑制功能。VIP 是维持 RegMos 中 IL-10 表达所必需的。这些数据表明,VIP 在治疗 RA 等免疫紊乱方面具有转化潜力。